Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.632
+0.052 (3.30%)
At close: Mar 6, 2026, 4:00 PM EST
1.600
-0.032 (-1.97%)
After-hours: Mar 6, 2026, 4:00 PM EST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $151.10 million as of March 6, 2026. Its market cap has decreased by -23.07% in one year.
Market Cap
151.10M
Enterprise Value
112.83M
1-Year Change
-23.07%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $151.10M, an increase of 20.67%. That is a compound annual growth rate of 1.47%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 167.61M |
| Rani Therapeutics Holdings | 165.27M |
| Zentalis Pharmaceuticals | 162.52M |
| Corbus Pharmaceuticals Holdings | 156.01M |
| Whitehawk Therapeutics | 153.17M |
| Immunic | 152.64M |
| Unicycive Therapeutics | 151.94M |
| Sangamo Therapeutics | 146.89M |